SG Americas Securities’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$362K Sell
38,585
-2,852
-7% -$26.8K ﹤0.01% 1694
2025
Q1
$295K Sell
41,437
-3,401
-8% -$24.2K ﹤0.01% 1981
2024
Q4
$523K Buy
44,838
+20,694
+86% +$241K ﹤0.01% 1130
2024
Q3
$496K Buy
24,144
+17,947
+290% +$369K ﹤0.01% 1497
2024
Q2
$139K Buy
6,197
+366
+6% +$8.21K ﹤0.01% 2077
2024
Q1
$160K Buy
+5,831
New +$160K ﹤0.01% 1911
2023
Q3
Sell
-9,552
Closed -$390K 2826
2023
Q2
$390K Sell
9,552
-10,627
-53% -$434K ﹤0.01% 1330
2023
Q1
$752K Buy
20,179
+219
+1% +$8.16K 0.01% 1266
2022
Q4
$696K Buy
19,960
+9,078
+83% +$317K 0.01% 1107
2022
Q3
$609K Buy
10,882
+3,863
+55% +$216K 0.01% 1194
2022
Q2
$363K Sell
7,019
-14,814
-68% -$766K ﹤0.01% 2026
2022
Q1
$1.59M Sell
21,833
-10,017
-31% -$728K 0.01% 942
2021
Q4
$3.77M Buy
31,850
+17,323
+119% +$2.05M 0.02% 565
2021
Q3
$1.95M Buy
14,527
+4,440
+44% +$596K 0.01% 1167
2021
Q2
$1.63M Sell
10,087
-1,199
-11% -$194K 0.01% 1137
2021
Q1
$906K Buy
11,286
+5,149
+84% +$413K ﹤0.01% 1471
2020
Q4
$334K Sell
6,137
-33,460
-85% -$1.82M ﹤0.01% 2013
2020
Q3
$787K Buy
39,597
+5,170
+15% +$103K 0.01% 1105
2020
Q2
$724K Buy
+34,427
New +$724K 0.01% 1471
2019
Q1
Sell
-8,239
Closed -$112K 2930
2018
Q4
$112K Buy
+8,239
New +$112K ﹤0.01% 2277
2018
Q2
Sell
-42,960
Closed -$906K 2921
2018
Q1
$906K Buy
+42,960
New +$906K 0.01% 1248
2017
Q4
Sell
-10,169
Closed -$253K 2830
2017
Q3
$253K Buy
10,169
+3,863
+61% +$96.1K ﹤0.01% 2076
2017
Q2
$101K Buy
+6,306
New +$101K ﹤0.01% 2544
2017
Q1
Sell
-36,794
Closed -$482K 2950
2016
Q4
$482K Buy
36,794
+9,979
+37% +$131K ﹤0.01% 1542
2016
Q3
$456K Buy
26,815
+9,306
+53% +$158K ﹤0.01% 1575
2016
Q2
$374K Buy
+17,509
New +$374K ﹤0.01% 1625